Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.41
IVC's Cash to Debt is ranked higher than
51% of the 392 Companies
in the Global Medical Devices industry.

( Industry Median: 2.71 vs. IVC: 0.41 )
IVC' s 10-Year Cash to Debt Range
Min: 0   Max: 0.43
Current: 0.41

0
0.43
Equity to Asset 0.60
IVC's Equity to Asset is ranked higher than
67% of the 373 Companies
in the Global Medical Devices industry.

( Industry Median: 0.62 vs. IVC: 0.60 )
IVC' s 10-Year Equity to Asset Range
Min: 0.32   Max: 0.61
Current: 0.6

0.32
0.61
F-Score: 4
Z-Score: 2.41
M-Score: -2.58
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -2.60
IVC's Operating margin (%) is ranked higher than
59% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 6.50 vs. IVC: -2.60 )
IVC' s 10-Year Operating margin (%) Range
Min: -2.6   Max: 10.8
Current: -2.6

-2.6
10.8
Net-margin (%) 2.44
IVC's Net-margin (%) is ranked higher than
69% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 4.71 vs. IVC: 2.44 )
IVC' s 10-Year Net-margin (%) Range
Min: -21.21   Max: 6.39
Current: 2.44

-21.21
6.39
ROE (%) 4.93
IVC's ROE (%) is ranked higher than
72% of the 377 Companies
in the Global Medical Devices industry.

( Industry Median: 5.57 vs. IVC: 4.93 )
IVC' s 10-Year ROE (%) Range
Min: -65.47   Max: 17.13
Current: 4.93

-65.47
17.13
ROA (%) 3.01
IVC's ROA (%) is ranked higher than
73% of the 392 Companies
in the Global Medical Devices industry.

( Industry Median: 3.23 vs. IVC: 3.01 )
IVC' s 10-Year ROA (%) Range
Min: -21.32   Max: 7.88
Current: 3.01

-21.32
7.88
ROC (Joel Greenblatt) (%) -15.06
IVC's ROC (Joel Greenblatt) (%) is ranked higher than
59% of the 391 Companies
in the Global Medical Devices industry.

( Industry Median: 12.89 vs. IVC: -15.06 )
IVC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -15.06   Max: 30.4
Current: -15.06

-15.06
30.4
Revenue Growth (%) -7.10
IVC's Revenue Growth (%) is ranked higher than
56% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 4.60 vs. IVC: -7.10 )
IVC' s 10-Year Revenue Growth (%) Range
Min: -7.1   Max: 17.3
Current: -7.1

-7.1
17.3
EBITDA Growth (%) -72.60
IVC's EBITDA Growth (%) is ranked lower than
51% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: -2.90 vs. IVC: -72.60 )
IVC' s 10-Year EBITDA Growth (%) Range
Min: -72.6   Max: 82.8
Current: -72.6

-72.6
82.8
» IVC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

IVC Guru Trades in Q3 2013

Richard Snow 104,095 sh (+25.7%)
Chuck Royce 1,334,261 sh (+3.31%)
Paul Tudor Jones Sold Out
Jim Simons 311,700 sh (-35.33%)
» More
Q4 2013

IVC Guru Trades in Q4 2013

Jim Simons 393,300 sh (+26.18%)
Chuck Royce 1,455,761 sh (+9.11%)
Richard Snow 56,925 sh (-45.31%)
» More
Q1 2014

IVC Guru Trades in Q1 2014

Paul Tudor Jones 12,300 sh (New)
Richard Snow Sold Out
Chuck Royce 1,329,161 sh (-8.7%)
Jim Simons 243,693 sh (-38.04%)
» More
Q2 2014

IVC Guru Trades in Q2 2014

HOTCHKIS & WILEY 1,243,400 sh (New)
Chuck Royce 1,689,436 sh (+27.11%)
Paul Tudor Jones Sold Out
Jim Simons 87,000 sh (-64.3%)
» More
» Details

Insider Trades

Latest Guru Trades with IVC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-06-30 Sold Out 0.04%$11.11 - $16.23 $ 15.3411%0
Joel Greenblatt 2013-03-31 New Buy0.04%$12.84 - $17.18 $ 15.340%66151
Joel Greenblatt 2012-06-30 Sold Out 0.08%$14.2 - $16.46 $ 15.341%0
Joel Greenblatt 2012-03-31 New Buy0.08%$15.49 - $17.94 $ 15.34-2%54104
Joel Greenblatt 2011-06-30 Sold Out 0.18%$31.15 - $33.58 $ 15.34-53%0
George Soros 2011-06-30 Sold Out $31.15 - $33.58 $ 15.34-53%0
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.77
IVC's P/B is ranked higher than
96% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 3.50 vs. IVC: 0.77 )
IVC' s 10-Year P/B Range
Min: 0.55   Max: 2.36
Current: 0.77

0.55
2.36
P/S 0.37
IVC's P/S is ranked higher than
98% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 3.21 vs. IVC: 0.37 )
IVC' s 10-Year P/S Range
Min: 0.23   Max: 1.21
Current: 0.37

0.23
1.21
PFCF 38.35
IVC's PFCF is ranked higher than
79% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. IVC: 38.35 )
IVC' s 10-Year PFCF Range
Min: 4.32   Max: 80.8
Current: 38.35

4.32
80.8
EV-to-EBIT -14.99
IVC's EV-to-EBIT is ranked higher than
52% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 57.01 vs. IVC: -14.99 )
IVC' s 10-Year EV-to-EBIT Range
Min: 10.2   Max: 168
Current: -14.99

10.2
168
Shiller P/E 29.59
IVC's Shiller P/E is ranked higher than
82% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. IVC: 29.59 )
IVC' s 10-Year Shiller P/E Range
Min: 10.84   Max: 35.92
Current: 29.59

10.84
35.92
Current Ratio 1.56
IVC's Current Ratio is ranked higher than
50% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 2.86 vs. IVC: 1.56 )
IVC' s 10-Year Current Ratio Range
Min: 1.44   Max: 2.75
Current: 1.56

1.44
2.75
Quick Ratio 0.95
IVC's Quick Ratio is ranked lower than
53% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 2.12 vs. IVC: 0.95 )
IVC' s 10-Year Quick Ratio Range
Min: 0.93   Max: 1.99
Current: 0.95

0.93
1.99

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.30
IVC's Dividend Yield is ranked lower than
88% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 1.17 vs. IVC: 0.30 )
IVC' s 10-Year Dividend Yield Range
Min: 0.1   Max: 0.46
Current: 0.3

0.1
0.46
Yield on cost (5-Year) 0.30
IVC's Yield on cost (5-Year) is ranked lower than
87% of the 182 Companies
in the Global Medical Devices industry.

( Industry Median: 1.23 vs. IVC: 0.30 )
IVC' s 10-Year Yield on cost (5-Year) Range
Min: 0.1   Max: 0.46
Current: 0.3

0.1
0.46
Share Buyback Rate 0.70
IVC's Share Buyback Rate is ranked higher than
90% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: -0.90 vs. IVC: 0.70 )
IVC' s 10-Year Share Buyback Rate Range
Min: 1.3   Max: -1.2
Current: 0.7

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 4.07
IVC's Price/Tangible Book is ranked higher than
75% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 6.09 vs. IVC: 4.07 )
IVC' s 10-Year Price/Tangible Book Range
Min: 3.31   Max: 94.61
Current: 4.07

3.31
94.61
Price/DCF (Projected) 0.42
IVC's Price/DCF (Projected) is ranked higher than
99% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. IVC: 0.42 )
IVC' s 10-Year Price/DCF (Projected) Range
Min: 0.33   Max: 36.46
Current: 0.42

0.33
36.46
Price/Median PS Value 0.80
IVC's Price/Median PS Value is ranked higher than
90% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 1.15 vs. IVC: 0.80 )
IVC' s 10-Year Price/Median PS Value Range
Min: 0.53   Max: 3.42
Current: 0.8

0.53
3.42
Earnings Yield (Greenblatt) 3.20
IVC's Earnings Yield (Greenblatt) is ranked higher than
61% of the 305 Companies
in the Global Medical Devices industry.

( Industry Median: 4.60 vs. IVC: 3.20 )
IVC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.6   Max: 9.8
Current: 3.2

0.6
9.8
Forward Rate of Return (Yacktman) 13.66
IVC's Forward Rate of Return (Yacktman) is ranked higher than
90% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 1.43 vs. IVC: 13.66 )
IVC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -3.8   Max: 19.6
Current: 13.66

-3.8
19.6

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:IV3.Germany
Invacare Corporation was incorporated in 1971. The Company manufactures and distributes medical equipment used in daily basis, based upon its distribution channels, breadth of product line and net sales. The Company designs, manufactures and distributes an extensive line of health care products for the non-acute care environment, including the home health care, retail and extended care markets. The Company sells its products mainly to over 25,000 home health care and medical equipment providers, distributors and government locations in the United States, Australia, Canada, Europe, New Zealand and Asia. The Company's products are sold through its worldwide distribution network by its sales force, telesales associates and various organizations of independent manufacturers' representatives and distributors. It also distributes medical equipment and disposable medical supplies, manufactured by others. The company operates in five primary business segments: North America/Home Medical Equipment or NA/HME, Invacare Supply Group, Institutional Products Group, Europe and Asia/Pacific. The NA/HME segment sells each of three primary product lines, which includes: standard, rehab and respiratory products. Invacare Supply Group sells distributed product and the Institutional Products Group sells health care furnishings and accessory products. Europe and Asia/Pacific sell the same product lines with the exception of distributed products. Each business segment sells to the home health care, retail and extended care markets. The Company manufactures a complete line of power wheelchairs for individuals who require independent powered mobility. The range includes products that could be significantly customized to meet an individual's specific needs, as well as products that are inherently versatile and meet a broad range of individual requirements. Power wheelchair lines are marketed under the Invacare(r) TDX(r) brand names and include a full range of powered mobility products. Invacare manufactures and markets a range of custom manual wheelchairs for everyday, sports and recreational uses. These lightweight chairs are marketed under the Invacare(r) and Invacare Top End(r) brand names. The Company manufactures and distributes a variety of manual, semi-electric and fully electric beds for home use under the Invacare(r) brand name. Home care bed accessories include bedside rails, mattresses, overbed tables, trapeze bars and traction equipment. Also available are new bariatric beds and accompanying accessories to serve the special needs of bariatric patients. Invacare manufactures and/or distributes home respiratory products, including: oxygen concentrators, HomeFill(r) oxygen delivery systems, sleep apnea products, aerosol therapy and associated respiratory product lines. The Company also manufactures markets and distributes accessory products that include spare parts, wheelchair cushions, arm rests, wheels and respiratory parts. In some cases, the
» More Articles for IVC

Headlines

Articles On GuruFocus.com
Invacare Corporation: Sell First, Ask Questions Later? Feb 15 2012 
Invacare Corp. Reports Operating Results (10-K) Feb 25 2011 
Invacare Corp. Reports Operating Results (10-Q) Nov 05 2010 
Invacare Corp. Reports Operating Results (10-Q) Aug 06 2010 
Invacare Corp. Reports Operating Results (10-Q) May 06 2010 
Invacare Corp. Reports Operating Results (10-Q) Nov 05 2009 
Invacare Corp. Reports Operating Results (10-Q) May 07 2009 
Invacare Corporation Reports Earnings within Guidance and Strong Free Cash Flow Jan 29 2009 
Invacare Corporation to Host Conference Call to Discuss Q4 2008 Results Jan 20 2009 
Weekly CEO Buys Highlight: American Water Works Company, Inc., CocaCola Enterprises Inc., SAVVIS Inc May 07 2008 

More From Other Websites
INVACARE CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements... Aug 29 2014
Invacare Corporation Announces Sale of Altimate Medical to Rockwood Equity Partners Aug 29 2014
INVACARE CORP Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Financial... Aug 21 2014
Invacare Corporation Announces Restructuring Initiative Aug 20 2014
INVACARE CORP Financials Aug 15 2014
Invacare Corp Stock Downgraded (IVC) Aug 15 2014
Invacare Declares Quarterly Dividend Aug 12 2014
INVACARE CORP Files SEC form 10-Q, Quarterly Report Aug 07 2014
What Falling Estimates & Price Mean for Invacare (IVC) Jul 31 2014
3 Stocks Pushing The Health Services Industry Downward Jul 24 2014
INVACARE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 24 2014
Q2 2014 Invacare Earnings Release - Before Market Open Jul 24 2014
Invacare CEO Gerald B. Blouch to retire Jul 24 2014
Gerald B. Blouch to Retire as President and Chief Executive Officer of Invacare Corporation Jul 24 2014
Invacare Corporation Announces Financial Results for the Second Quarter of 2014 Jul 24 2014
Invacare Corporation to Host Conference Call to Discuss Second Quarter 2014 Financial Results Jul 09 2014
Invacare President and Chief Executive Officer Presenting at CJS Securities Summer Conference Jul 02 2014
Invacare Corporation to Present at Jefferies 2014 Global Healthcare Conference May 20 2014
INVACARE CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 16 2014
Michael Merriman Joins Board of Directors of Invacare Corporation May 15 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK